A 14-year-old boy with longstanding multisystem Langerhans cell histiocytosis (LCH) had multifocal bone pain unresponsive to chemotherapy, corticosteroids, anti-inflammatories, and narcotic analgesics. He responded to two cycles of intravenous pamidronate, each 90 mg per day on three consecutive days. Two subsequent episodes of deterioration also responded to treatment. The pathophysiology of his bone pain and the likely mechanisms of biphosphonate action are discussed, with emphasis on the molecular and cellular basis of LCH. © 2001 Lippincott Williams & Wilkins, Inc.
CITATION STYLE
Peter Farran, R., Zaretski, E., & Maarten Egeler, R. (2001). Treatment of langerhans cell histiocytosis with pamidronate. American Journal of Pediatric Hematology/Oncology, 23(1), 54–56. https://doi.org/10.1097/00043426-200101000-00013
Mendeley helps you to discover research relevant for your work.